PMI allowed to make modified risk claims in US for Iqos 3 but import ban stands

The US Food and Drug Administration (FDA) is allowing Philip Morris International (PMI) to market its Iqos 3 heated tobacco device with some reduced risk claims. The decision does not override the current ban by the International Trade Commission (ITC) on Iqos sales and imports but opens the door for the company to cite the authorisation in future marketing.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo